Novocell, a stem cell engineering company, hired Alan Lewis, Ph.D., as president and CEO.
Wyeth has named Bernard Poussot president and vice chairman of the company and promoted CFO Kenneth Martin to vice chairman.
Symphony Capital, a private equity firm focused on the clinical development of biopharmaceutical products, announced that Dr. Alastair J. J. Wood of Vanderbilt will join Symphony Capital in September 2006 as a Managing Director.
DURECT announced that Peter J. Langecker, M.D., Ph.D., has joined the company as chief medical officer.
VirtualScopics has named Jeffrey Markin as COO.
Protedyne, a laboratory automation provider, announced that Roch Kelly has joined the company's management team as chief operating officer.
Hemagen Diagnostics announced that Deborah F. Ricci has resigned her position as secretary and CFO.
Fovea Pharmaceuticals has appointed Dr. Barrett Katz, MD, MBA, as executive vice-president and chief medical officer.
A veteran team of five former Glaxo executives has joined Trana Discovery. They include Steve Peterson, now CEO of Trana Discovery.
Coley Pharmaceutical Group has appointed Ferdinand E. Massari, M.D., to the position of senior vice president, drug development and chief medical officer.
Biovail has hired Gilbert Godin to become its senior vice-president, technical operations/drug delivery.
CytoCore named Dr. George Gorodeski lead research scientist as well as head of the company's medical advisory board.
MIGENIX has named AnnKatrin Petersen, M.D. vice president of clinical development.
Altus Pharmaceuticals has named Lauren Sabella vice president, commercial development.
Jerini has hired Andrew D. Curtis as vice president U.S. marketing.
RHEI Pharmaceuticals has named Scott Kozak vice president of commercial operations.
BrainStorm Cell Therapeutics has hired Dr. Holly G. Atkinson to serve as contract director of business development.
Replikun Biotech has appointed Dr. Nick Samaras as chairman of their board of directors.
Andrew J. Perlman, M.D., Ph.D., has joined ISTA Pharmaceuticals' board of directors.
Ondine Biopharma has named Michael Richard Crane to its board of directors.
Novavax has elected James B. Tananbaum, M.D., as a director.
HemoSense announced the appointment of Harvey Schloss to its board of directors and as a member of the audit committee.